XXF Announces Board Reshuffle: Executive Exits, Prof. Wang Joins as Independent Director and Committee Chair

Bulletin Express
10/15

On 15 October 2026, XXF Group Holdings Limited (XXF, HKEX: 02473) unveiled a series of governance changes that will reshape its board and key committees over the next month.

Effective 15 October 2026, Executive Director Ms. Zhang Jinghua resigned from the board, the Nomination Committee, and her role as Authorised Representative. Non-Executive Director Mr. Liu Wei also stepped down. Both cited personal commitments and confirmed no disagreements with the board.

On the same date, Prof. Wang Lihong, aged 45, was appointed as an Independent Non-Executive Director and immediately joined the Nomination Committee. Prof. Wang holds a Ph.D. in Finance from KU Leuven and serves as a professor at Xiamen University’s Institute for Financial & Accounting Studies. Her three-year term carries annual remuneration of RMB0.12 million.

Further succession moves take effect on 9 November 2026. Incumbent Independent Non-Executive Director Mr. Wu Fei will retire, relinquishing roles on the Nomination and Audit Committees and as chairman of the Remuneration Committee. Prof. Wang will assume Mr. Wu’s positions on both committees, becoming chairman of the Remuneration Committee and a member of the Audit Committee.

To fill the Authorised Representative vacancy created by Ms. Zhang’s departure, Company Secretary Ms. Mak Po Man Cherie has been appointed to the role from 15 October 2026.

Chairman and CEO Mr. Huang Wei expressed appreciation for the outgoing directors’ contributions and welcomed Prof. Wang to the board. Following these changes, the board comprises two Executive Directors—Mr. Huang Wei and Mr. Ye Fuwei—and four Independent Non-Executive Directors: Mr. Wu Fei (until 9 November 2026), Mr. Fung Che Wai Anthony, Mr. Chen Shuo, and Prof. Wang Lihong.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10